USFDA asks Philips Respironics to notify patients about ventilator recall
"Taking this action today enables the FDA to mandate that Philips Respironics improve its communication about the recall and the serious risk posed by the foam used in the recalled products with patients," the regulator added.
New Delhi: The U.S. Food and Drug Administration (FDA) asked Dutch medical equipment maker Philips Respironics on Thursday to notify patients about the company's recall of certain ventilators and other breathing assistance machines in June last year.
Read Also - Philips expanded ventilator recall classified as most serious by USFDA
Philips invasive and noninvasive ventilators support the needs of the patient and care providers from hospital through the home. Our solutions are designed to deliver the highest possible clinical and patient experience. The final goal of our partnership is to help care providers and health systems as they navigate complex and changing patient conditions and care settings when treating respiratory insufficiency.
Read Also - Philips, USFDA in talks post new ventilator findings
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.